Bioelectronics Corp (BIEL)

[4toSchool]

Crunching the numbers raises some concerns:

The "Other G&A" expense line had an average quarterly spend of $215k for the first three quarters. However, Quarter 4 saw the spend at only $29k. What was cut? Was it important for the company? If not, why and on what were we spending $215k per quarter?

...and why are over 1/3 of the operational expenses lumped into an "OTHER G&A" account. Makes me wonder if someone wants to hide payroll figures.

Similar cutbacks for "Sales Support". The first three quarters averaged $98k spending, while the 4th quarter dropped to $36k. What was cut? Was it important for the company? If not, why and on what were we spending $215k per quarter?

R&D was reduced by nearly $40k during the 4th quarter, versus the first three quarters. What was cut? Was it important for the company? If not, why and on what were we spending $215k per quarter?

Why did the 'Cost of Goods Sold' to 'Sales' ratio increase from an average of 32% during the first three quarters to 64% in the fourth quarter? This caused the Gross Profit to drop from 68% during the first 9-months of 2019 to only 36% during the 4th quarter.

Something isn't right.